US Broker Ratings

Takeda Pharmaceutical Company (TAK) Stock Analysis: Navigating a 23.67% Potential Upside

For investors focusing on the healthcare sector, Takeda Pharmaceutical Company Limited (NYSE: TAK) presents a compelling opportunity. With a market capitalization of $47.19 billion, this Japanese giant is a prominent..

Natera, Inc. (NTRA) Stock Analysis: Navigating the Diagnostics Giant’s Promising Growth and Challenges

In the rapidly evolving field of healthcare diagnostics, Natera, Inc. (NASDAQ: NTRA) stands out as a heavyweight player with a market capitalization of $33.75 billion. Headquartered in Austin, Texas, Natera..

BioNTech SE (BNTX) Investor Outlook: Unpacking a 42.9% Potential Upside Amidst Biotech Innovations

BioNTech SE (NASDAQ: BNTX) continues to capture the attention of investors with its impressive portfolio of clinical trials and a notable potential upside of 42.9%. As a pioneering force in..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating a 23.7% Revenue Growth Amid a Mixed Analyst Consensus

Medpace Holdings, Inc. (NASDAQ: MEDP), a pivotal player in the healthcare sector, has been capturing significant attention in the diagnostics and research industry. With a robust market capitalization of $15.44..

Baxter International Inc. (BAX)

⚠️ No article content returned.

..

UnitedHealth Group (UNH) Stock Analysis: Exploring a 17% Upside Potential Amid Robust Revenue Growth

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, commands a market capitalization of $299.75 billion, making it a formidable player in the healthcare plans industry. Headquartered in..

Koninklijke Philips N.V. (PHG) Stock Analysis: Potential 25% Upside Amid Healthcare Innovation

Koninklijke Philips N.V. (NYSE: PHG), a leading player in the global healthcare sector, offers a compelling investment opportunity as it navigates the evolving landscape of medical technology. With a robust..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Insights into a $15.4 Billion Biotech Powerhouse

Revolution Medicines, Inc. (RVMD), a prominent player in the biotechnology sector, is making waves with its ambitious approach to tackling RAS-addicted cancers. Headquartered in Redwood City, California, this clinical-stage precision..

Henry Schein, Inc. (HSIC) Stock Analysis: Evaluating Growth Potential in the Healthcare Sector

Henry Schein, Inc. (NASDAQ: HSIC) stands as a formidable player in the healthcare sector, specializing in medical distribution with a focus on office-based dental and medical practitioners. With a market..

Charles River Laboratories (CRL) Stock Analysis: Navigating Growth in the Healthcare Diagnostics Sector

Charles River Laboratories International, Inc. (NYSE: CRL) is a prominent player in the healthcare diagnostics and research industry, providing a wide array of drug discovery and safety testing services on..

Incyte Corporation (INCY) Stock Analysis: Navigating Biotech Innovation with Strong Revenue Growth and Robust Analyst Ratings

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, is catching the attention of investors with its strong revenue growth and a diverse portfolio of therapeutics. Headquartered in..

Mettler-Toledo International (MTD) Stock Analysis: Navigating a 5.83% Potential Upside in the Diagnostics & Research Sector

Mettler-Toledo International Inc. (NYSE: MTD) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a commanding market capitalization of $29.14 billion, this..

ICON plc (ICLR)

⚠️ No article content returned.

..

Exelixis, Inc. (EXEL) Stock Analysis: Unlocking Oncology Innovations with Strong Investor Support

Exelixis, Inc. (NASDAQ: EXEL) is a notable player in the biotechnology sector, specifically focused on oncology, with a market capitalization of $11.94 billion. The company’s innovative approach to developing medicines..

Pfizer, Inc. (PFE) Stock Analysis: Evaluating a 6.61% Dividend Yield Amidst a Complex Market Landscape

Pfizer, Inc. (PFE), a titan in the healthcare sector and a key player in the drug manufacturing industry, commands a substantial market capitalization of $148 billion. The company is renowned..

Cencora, Inc. (COR) Stock Analysis: Unveiling a 13% Upside Potential in the Booming Healthcare Sector

Cencora, Inc. (NYSE: COR), a key player in the healthcare sector, stands out in the medical distribution industry with a considerable market capitalization of $65.89 billion. Formerly known as AmerisourceBergen..

BeOne Medicines Ltd. (ONC) Stock Analysis: Robust Analyst Ratings Signal 24% Potential Upside

Investors with an eye on the healthcare sector, particularly biotechnology, should take note of BeOne Medicines Ltd. (ONC). Based in Basel, Switzerland, this company is making waves with its innovative..

DaVita Inc. (DVA) Stock Analysis: A 23% Potential Upside in the Healthcare Sector

DaVita Inc. (NYSE: DVA), a leading player in the healthcare sector specializing in kidney dialysis services, has been capturing the attention of investors with its promising potential for growth. Despite..

Bio-Techne Corp (TECH) Stock Analysis: Assessing a 12% Upside Potential with Strong Buy Ratings

Bio-Techne Corporation (NASDAQ: TECH), a prominent player in the healthcare sector under the biotechnology industry, is capturing investor attention with a compelling forecast of a 12.14% potential upside. This company,..

DexCom, Inc. (DXCM) Stock Analysis: Strong Buy Ratings and a 29% Potential Upside Make It a Standout in Medical Devices

DexCom, Inc. (DXCM), a leading player in the healthcare sector, is making waves in the medical devices industry with its innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds